SEC Form 4 · accession 0001437749-15-019484
Vaxart, Inc. · VXRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark P Colonnese
Officer — Chief Financial Officer
Period of report
Nov 2, 2015
Accepted (ET)
Nov 3, 2015 · 2:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000072444
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.02 | Nov 2, 2015 | A | 225,000 | A | Nov 2, 2016 | Nov 2, 2025 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1This stock option vests in equal annual installments beginning on the first, second, and third anniversary of the date ratably.